Sol-Gel Technologies Statistics
NASDAQ: SLGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
71.95-3.69 (-4.88%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Sol-Gel Technologies by the numbers
Sol-Gel Technologies has a market capitalization of $235.5 million based on 3.27M shares outstanding. With trailing EPS of $-5.61, Sol-Gel Technologies is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.9% below its 50-day average and 0.4% below its 200-day average.
Average daily trading volume is 55.46K shares, or about $4.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SLGL valuation vs. peer median
| Metric | SLGL | Peer median | Difference |
|---|---|---|---|
| Market cap | $235.55M | $246.92M | -5% |
| Avg. volume | 55.46K | 442.00K | -87% |
Peer median across 8 companies: IMRX, ZNTL, LFCR, VCRE, UPB, AKBA, AMRN, CAMP.
Valuation
- Market cap
- $235.55M
- EPS (TTM)
- $-5.61
- Shares outstanding
- 3.27M
Price and trading
- Previous close
- 75.64
- Open
- 75.04
- Day range
- 71.28 – 75.07
- 52-week range
- 28.81 – 97.97
- 52-week change
- +75.52%
- Beta
- —
- Volume
- 31.33K
- Average volume
- 55.46K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 20, 2026
Additional statistics
- Market Cap
- 235.55M
- Forward Pe
- -8.61
- Eps
- -5.61
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 97.97
- Week52 Low
- 28.81
- Avg Volume
- 55,456.00
- Shares Outstanding
- 3.27M
- Ma50
- 74.06
- Ma200
- 72.25
- Earnings Date
- Aug 20, 2026
- Pct From52w High
- -26.56%
- Pct From52w Low
- 149.72%